litlas
Log inCreate account

Rob A.�E.�M. Tollenaar

Active 1998–2025

Also published as
Rob A. E. M. Tollenaar
153
Papers
21,673
Citations
81
h-index
148
i10-index

Citations

Citations per year for Rob A.�E.�M. Tollenaar1967: 1 citations1969: 1 citations1998: 1 citations1999: 14 citations2000: 13 citations2001: 17 citations2002: 14 citations2003: 14 citations2004: 22 citations2005: 52 citations2006: 56 citations2007: 122 citations2008: 192 citations2009: 185 citations2010: 199 citations2011: 203 citations2012: 230 citations2013: 231 citations2014: 245 citations2015: 237 citations2016: 258 citations2017: 211 citations2018: 206 citations2019: 608 citations2020: 671 citations2021: 685 citations2022: 497 citations2023: 312 citations2024: 536 citations2025: 219 citations2026: 9 citations1968: no citations, so this year is not shown1970–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,044 citing papers, 20.6% of this breakdownNetherlands: 826 citing papers, 8.3% of this breakdownUnited Kingdom: 753 citing papers, 7.6% of this breakdownChina: 731 citing papers, 7.4% of this breakdownGermany: 575 citing papers, 5.8% of this breakdownItaly: 412 citing papers, 4.2% of this breakdownCanada: 346 citing papers, 3.5% of this breakdownFrance: 343 citing papers, 3.5% of this breakdownAustralia: 335 citing papers, 3.4% of this breakdownSpain: 295 citing papers, 3% of this breakdownSweden: 251 citing papers, 2.5% of this breakdownJapan: 235 citing papers, 2.4% of this breakdown
0%20.6%Other 27.8%

Institutions

Fields

  • Medicine50%
  • Biochemistry, Genetics and Molecular Biology38.5%
  • Immunology and Microbiology2.7%
  • Computer Science2.4%
  • Chemistry2%
  • Neuroscience1.1%
  • Other3.3%

Topics

  • Colorectal Cancer Surgical Treatments4.5%
  • BRCA gene mutations in cancer4.3%
  • Epigenetics and DNA Methylation3.3%
  • Breast Cancer Treatment Studies3%
  • Genetic factors in colorectal cancer2.5%
  • Cancer Genomics and Diagnostics2.4%
  • Other80%

Coauthors

All papers

Open in search
  1. Focusing on desired outcomes of care after colon cancer resections; hospital variations in ‘textbook outcome’

    Authors: N.E. Kolfschoten, J. Kievit, G.A. Gooiker, Nicoline J. van Leersum, H.S. Snijders, E.H. Eddes, Rob A.�E.�M. Tollenaar, Michel W.J.M. Wouters, Perla J. Marang‐van de Mheen - European Journal of Surgical Oncology 2012 cited by 329

  2. The Carcinoma–Stromal Ratio of Colon Carcinoma Is an Independent Factor for Survival Compared to Lymph Node Status and Tumor Stage

    Authors: Wilma E. Mesker, Jan M. C. Junggeburt, Károly Szuhai, Pieter de Heer, Hans Morreau, Hans J. Tanke, Rob A.�E.�M. Tollenaar - Analytical Cellular Pathology 2007 cited by 354

  3. Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina–associated domains

    Authors: Benjamin P. Berman, Daniel J. Weisenberger, Joseph F Aman, Toshinori Hinoue, Zachary Ramjan, Yaping Liu, Houtan Noushmehr, Christopher P.E. Lange, Cornelis M. van Dijk, Rob A.�E.�M. Tollenaar, David Van Den Berg, Peter W. Laird - Nature Genetics 2011 cited by 690

  4. The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial

    Authors: A. Huijbers, Rob A.�E.�M. Tollenaar, Gabi W. van Pelt, Eliane C.M. Zeestraten, Susan Dutton, Christopher C. McConkey, Enric Domingo, Vincent T.H.B.M. Smit, Rachel Midgley, B F Warren, Elaine Johnstone, David Kerr, Wilma E. Mesker - Annals of Oncology 2012 cited by 345

  5. LncRNA LITATS1 suppresses TGF‐β‐induced EMT and cancer cell plasticity by potentiating TβRI degradation

    Authors: Chuannan Fan, Qian Wang, Thomas B. Kuipers, Davy Cats, Prasanna Vasudevan Iyengar, Sophie C. Hagenaars, Wilma E. Mesker, Peter Devilee, Rob A.�E.�M. Tollenaar, Hailiang Mei, Peter ten Dijke - The EMBO Journal 2023 cited by 69

  6. Scoring the tumor-stroma ratio in colon cancer: procedure and recommendations

    Authors: Gabi W. van Pelt, Sanne Kjær‐Frifeldt, J. Han van Krieken, Raed Al Dieri, Hans Morreau, Rob A.�E.�M. Tollenaar, Flemming Brandt Sørensen, Wilma E. Mesker - Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 2018 cited by 184

  7. Genome-scale analysis of aberrant DNA methylation in colorectal cancer

    Authors: Toshinori Hinoue, Daniel J. Weisenberger, Christopher P.E. Lange, Hui Shen, Hyang‐Min Byun, David Van Den Berg, Simeen Malik, Fei Pan, Houtan Noushmehr, Cornelis M. van Dijk, Rob A.�E.�M. Tollenaar, Peter W. Laird - Genome Research 2011 cited by 601

  8. MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial

    Authors: Sepideh Saadatmand, H. Amarens Geuzinge, Emiel J. Rutgers, Ritse M. Mann, Diderick B. W. de Roy van Zuidewijn, Harmien M. Zonderland, Rob A.�E.�M. Tollenaar, Marc B. I. Lobbes, Margreet G.E.M. Ausems, Martijne van ’t Riet, Maartje J. Hooning, Ingeborg Mares-Engelberts, Ernest J. T. Luiten, Eveline A.M. Heijnsdijk, Cees Verhoef, Nico Karssemeijer, Jan C. Oosterwijk, Inge-Marie Obdeijn, Harry J. de Koning, Madeleine M.A. Tilanus‐Linthorst, Carolien HM van Deurzen, Claudette E. Loo, Jelle Wesseling, Margrethe Schlooz-Vries, Suzan van der Meij, Wilma E. Mesker, Kristien Keymeulen, Carolien Contant, Eva V. E. Madsen, Linetta B. Koppert, Joost Rothbarth, Wouter B. Veldhuis, Arjen J. Witkamp, Eric Tetteroo, Cecile de Monyé, Mandy M van Rosmalen, J. Remmelzwaal, Huub B W Gort, Roelie Roi-Antonides, Martin N.J.M. Wasser, Edith van Druten - The Lancet Oncology 2019 cited by 172

  9. Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer

    Authors: Tessa P. Sandberg, Maaike P. M. E. Stuart, Jan Oosting, Rob A.�E.�M. Tollenaar, Cornelis F.M. Sier, Wilma E. Mesker - BMC Cancer 2019 cited by 142

  10. Postoperative complications after colorectal cancer surgery and the association with long-term survival

    Authors: Anne‐Loes K. Warps, Rob A.�E.�M. Tollenaar, Pieter J. Tanis, Jan Willem T. Dekker - European Journal of Surgical Oncology 2021 cited by 62

  11. Nuclear receptor NR4A1 promotes breast cancer invasion and metastasis by activating TGF-β signalling

    Authors: Fangfang Zhou, Yvette Drabsch, Tim Dekker, Amaya García de Vinuesa, Yihao Li, Lukas J.A.C. Hawinkels, Kelly-Ann Sheppard, Marie‐José Goumans, Rodney B. Luwor, Carlie J.M. de Vries, Wilma E. Mesker, Rob A.�E.�M. Tollenaar, Peter Devilee, Chuang Lu, Hong‐Jian Zhu, Long Zhang, Peter ten Dijke - Nature Communications 2014 cited by 180

  12. The tumour–stroma ratio in colon cancer: the biological role and its prognostic impact

    Authors: Gabi W. van Pelt, Tessa P. Sandberg, Hans Morreau, Hans Gelderblom, J. Han van Krieken, Rob A.�E.�M. Tollenaar, Wilma E. Mesker - Histopathology 2018 cited by 160

  13. Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer

    Authors: Ramón Salazar, Paul Roepman, Gabriel Capellá, Vı́ctor Moreno, Iris Simón, Christa Dreezen, Adriana López‐Doriga, Cristina Santos, Corrie A.M. Marijnen, Johan Westerga, Sjoerd C. Bruin, David Kerr, Peter J.K. Kuppen, Cornelis J.�H. van de Velde, Hans Morreau, Loes Van Velthuysen, Annuska M. Glas, Laura J. van’t Veer, Rob A.�E.�M. Tollenaar - Journal of Clinical Oncology 2010 cited by 540

  14. Patient-Related Prognostic Factors for Anastomotic Leakage, Major Complications, and Short-Term Mortality Following Esophagectomy for Cancer: A Systematic Review and Meta-Analyses

    Authors: Robert T. van Kooten, Daan M. Voeten, Ewout W. Steyerberg, Henk H. Hartgrink, Mark I. van Berge Henegouwen, Richard van Hillegersberg, Rob A.�E.�M. Tollenaar, Michel W.J.M. Wouters - Annals of Surgical Oncology 2021 cited by 91

  15. N-Glycomic Signature of Stage II Colorectal Cancer and Its Association With the Tumor Microenvironment

    Authors: Fanny Boyaval, René van Zeijl, Hans Dalebout, Stephanie Holst, Gabi W. van Pelt, Arantza Fariña Sarasqueta, Wilma E. Mesker, Rob A.�E.�M. Tollenaar, Hans Morreau, Manfred Wuhrer, Bram Heijs - Molecular & Cellular Proteomics 2020 cited by 74

  16. Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition

    Authors: Mieke Kriege, Cecile T.M. Brekelmans, C. Boetes, Peter E. Besnard, Harmine M. Zonderland, Inge Marie Obdeijn, Radu A. Manoliu, Theo M. de Kok, Hans Peterse, Madeleine M.A. Tilanus‐Linthorst, Sara Müller, Sybren Meijer, Jan C. Oosterwijk, L.V.A.M. Beex, Rob A.�E.�M. Tollenaar, Harry J. de Koning, Emiel J. Rutgers, Jan G.M. Klijn - New England Journal of Medicine 2004 cited by 1,690

  17. The Dutch Surgical Colorectal Audit

    Authors: Nicoline J. van Leersum, H.S. Snijders, D. Henneman, N.E. Kolfschoten, G.A. Gooiker, Martijn Geert ten Berge, E.H. Eddes, Michel W.J.M. Wouters, Rob A.�E.�M. Tollenaar, Willem A. Bemelman, Ronald M. van Dam, Marloes A.G. Elferink, T.M. Karsten, J.H.J.M. van Krieken, V.E.P.P. Lemmens, H.J.T. Rutten, Eric R. Manusama, Cornelis J.�H. van de Velde, W. J. H. J. Meijerink, Th. Wiggers, E. van der Harst, Jan Willem T. Dekker, Djamila Boerma - European Journal of Surgical Oncology 2013 cited by 360

  18. Multimodal Mass Spectrometry Imaging of N-Glycans and Proteins from the Same Tissue Section

    Authors: Bram Heijs, Stephanie Holst, Inge H. Briaire‐de Bruijn, Gabi W. van Pelt, Arnoud H. de Ru, Peter A. van Veelen, Richard R. Drake, Anand S. Mehta, Wilma E. Mesker, Rob A.�E.�M. Tollenaar, Judith V.M.G. Bovée, Manfred Wuhrer, Liam A. McDonnell - Analytical Chemistry 2016 cited by 107

  19. Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk

    Authors: H. Amarens Geuzinge, Inge-Marie Obdeijn, Emiel J. Rutgers, Sepideh Saadatmand, Ritse M. Mann, Jan C. Oosterwijk, Rob A.�E.�M. Tollenaar, Diderick B. W. de Roy van Zuidewijn, Marc B. I. Lobbes, Martijne van ’t Riet, Maartje J. Hooning, Margreet G.E.M. Ausems, Claudette E. Loo, Jelle Wesseling, Ernest J. T. Luiten, Harmien M. Zonderland, Cees Verhoef, Eveline A.M. Heijnsdijk, Madeleine M.A. Tilanus‐Linthorst, Harry J. de Koning, for the Familial MRI Screening (FaMRIsc) Study group - JAMA Oncology 2020 cited by 52

  20. Genome-wide association study identifies novel breast cancer susceptibility loci

    Authors: Douglas F. Easton, Karen A. Pooley, Alison M. Dunning, Paul D.P. Pharoah, Deborah J. Thompson, Dennis G. Ballinger, Jeffery P. Struewing, Jonathan J. Morrison, Helen I. Field, Robert Luben, Nicholas J. Wareham, Shahana Ahmed, Catherine S. Healey, Richard Bowman, The SEARCH collaborators, Craig Luccarini, Don Conroy, Mitul Shah, Hannah Munday, Clare Jordan, Barbara Perkins, Judy West, Karen Redman, Kristy Driver, Kerstin B. Meyer, Christopher A. Haiman, Laurence Kolonel, Brian E. Henderson, Loı̈c Le Marchand, Paul Brennan, Suleeporn Sangrajrang, Valérie Gaborieau, Fabrice Odefrey, Chen‐Yang Shen, Pei‐Ei Wu, Hui‐Chun Wang, Diana Eccles, D. Gareth Evans, Julian Peto, Olivia Fletcher, Nichola Johnson, Sheila Seal, Michael R. Stratton, Nazneen Rahman, Georgia Chenevix-Trench, Stig E. Bojesen, Børge G. Nordestgaard, C. K. Axelsson, Montserrat García‐Closas, Louise A. Brinton, Stephen J. Chanock, Jolanta Lissowska, Beata Pepłońska, Heli Nevanlinna, Rainer Fagerholm, Hannaleena Eerola, Daehee Kang, Keun-Young Yoo, Dong‐Young Noh, Sei Hyun Ahn, David J. Hunter, Susan E. Hankinson, David G. Cox, Per Hall, Sara Wedrén, Jianjun Liu, Yen-Ling Low, Natalia Bogdanova, Peter Schürmann, Thilo Dörk, Rob A.�E.�M. Tollenaar, Catharina E. Jacobi, Peter Devilee, Jan G.M. Klijn, Alice J. Sigurdson, Michele M. Doody, Bruce H. Alexander, Jinghui Zhang, Angela Cox, Ian W. Brock, Gordon R. Macpherson, Malcolm Reed, Fergus J. Couch, Ellen L. Goode, Janet E. Olson, Hanne Meijers‐Heijboer, Ans van den Ouweland, André G. Uitterlinden, Fernando Rivadeneira, Roger L. Milne, Gloría Ribas, Anna González‐Neira, Javier Benı́tez, John L. Hopper, Margaret McCredie, Melissa Southey, Graham G. Giles, Chris Schroen, Christina Justenhoven, Hiltrud Brauch and 139 more - Nature 2007 cited by 2,342

  21. The Dutch Institute for Clinical Auditing

    Authors: Naomi Beck, Annelotte C van Bommel, E.H. Eddes, Nicoline J. van Leersum, Rob A.�E.�M. Tollenaar, Michel W.J.M. Wouters - Annals of Surgery 2020 cited by 92

  22. Predictors of 30-Day Mortality Among Dutch Patients Undergoing Colorectal Cancer Surgery, 2011-2016

    Authors: Tom van den Bosch, Anne‐Loes K. Warps, Michael P.M. de Neree tot Babberich, C Stamm, Bart F. Geerts, Louis Vermeulen, Michel W.J.M. Wouters, Jan Willem T. Dekker, Rob A.�E.�M. Tollenaar, Pieter J. Tanis, Daniël M. Miedema, Dutch ColoRectal Audit - JAMA Network Open 2021 cited by 81

  23. The prognostic value of the tumor–stroma ratio is most discriminative in patients with grade III or triple‐negative breast cancer

    Authors: Kiki M. H. Vangangelt, Andrew R. Green, Isabelle M.F. Heemskerk, Daniëlle Cohen, Gabi W. van Pelt, Marcelo Sobral‐Leite, Marjanka K. Schmidt, Hein Putter, Emad A. Rakha, Rob A.�E.�M. Tollenaar, Wilma E. Mesker - International Journal of Cancer 2020 cited by 71

  24. Preoperative risk factors for major postoperative complications after complex gastrointestinal cancer surgery: A systematic review

    Authors: Robert T. van Kooten, Renu R. Bahadoer, Koen Peeters, Jetty H.L. Hoeksema, Ewout W. Steyerberg, Henk H. Hartgrink, Cornelis J.�H. van de Velde, Michel W.J.M. Wouters, Rob A.�E.�M. Tollenaar - European Journal of Surgical Oncology 2021 cited by 60